SCHEMBL30808172

SCHEMBL30808172

Cc1cc(C(C)O)c2nc(N3CCCCC3)cnc2c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MET P08581 4/20 0.46
▸ SORD Q00796 2/20 0.40
▸ AKT1 P31749 2/20 0.39
▸ AKT2 P31751 2/20 0.39
▸ AKT3 Q9Y243 2/20 0.39
▸ KDM4E B2RXH2 4/20 0.36
▸ GAA P10253 3/20 0.36
▸ L3MBTL1 Q9Y468 3/20 0.36
▸ TDP1 Q9NUW8 1/20 0.36
▸ CRHBP P24387 1/20 0.35
▸ CRHR2 Q13324 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ ACHE P22303 1/20 0.35
▸ CNR2 P34972 1/20 0.34
▸ PIK3CA P42336 3/20 0.34
▸ CCR4 P51679 1/20 0.34
▸ MAP4K4 O95819 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ POLB P06746 1/20 0.34
▸ HPGD P15428 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30808227 0.96 MET (0.46) METSORDAKT1AKT2AKT3
SCHEMBL30808200 0.88 MET (0.41) METSORDAKT1AKT2AKT3
SCHEMBL30808201 0.79 MET (0.49) METKDM4EGAAL3MBTL1TDP1
SCHEMBL30808207 0.78 MET (0.44) METKDM4EGAACRHBPCRHR2
SCHEMBL30808162 0.77 SMN1; SMN2 (0.48) METAKT1AKT2AKT3KDM4E
SCHEMBL30808192 0.77 MET (0.50) METKDM4EGAAL3MBTL1TDP1
SCHEMBL30808197 0.74 MET (0.50) METKDM4EGAAL3MBTL1TDP1
SCHEMBL30808182 0.74 MET (0.45) METSORDKDM4ECNR2PIK3CA
SCHEMBL18739111 0.74 PIK3CD (0.43) SORDSMN1; SMN2PIK3CAPIK3CDPIK3CB
SCHEMBL30762614 0.73 KDM4E (0.42) AKT1AKT2AKT3KDM4EGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024026419-A1 QUINOXALINE DERIVATIVES AS PIK3 ALPHA MODULATORS BLACK DIAMOND THERAPEUTICS, INC. (US) 2024-02-01 — — WO disclosed
Send feedback